NDC 24979-710
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
Paclitaxel
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) is a Intravenous Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Twi Pharmaceuticals, Inc.. The primary component is Paclitaxel.
Product ID | 24979-710_1f41135d-3da4-45b2-9462-6482256fa728 |
NDC | 24979-710 |
Product Type | Human Prescription Drug |
Proprietary Name | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) |
Generic Name | Paclitaxel |
Dosage Form | Injection, Powder, Lyophilized, For Suspension |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-04-01 |
Marketing Category | NDA AUTHORIZED GENERIC / |
Application Number | NDA021660 |
Labeler Name | TWi Pharmaceuticals, Inc. |
Substance Name | PACLITAXEL |
Active Ingredient Strength | 100 mg/20mL |
Pharm Classes | Microtubule Inhibition [PE], Microtubule Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |